LAG-3 protein structure may be the key to unlocking new cancer treatments

A molecular “snapshot” of a protein can be critical to understanding its function. Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer treatments.

M1 Kliniken AG (von First Berlin Equity Research GmbH) – Biotech Investments

Original-Research: M1 Kliniken AG – von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu M1 Kliniken AG Unternehmen: M1 Kliniken

June 27, 2023

BeiGene strikes deal worth $1.3bn with Ensem for CDK2 inhibitor – Pharmaceutical Technology

Share this article Ensem’s CDK2 inhibitor blocks the activity of cyclin-dependent kinase 2, thereby targeting uncontrolled cell growth. Credit: andresr via Getty Images. BeiGene has

November 21, 2023

Breakthrough blood test developed for early detection of sarcoidosis

A research project led by Lobelia Samavati, M.D., professor of internal medicine and molecular medicine and genetics at the Wayne State University School of Medicine,

February 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.